Diagnostic Performance of 68Ga-PSMA-11 PET/CT Compared with Multiparametric MRI for Initial Local Staging of Prostate Cancer
Background/Objectives: Prostate-specific membrane antigen positron emission tomography/computed tomography (PSMA PET/CT) remains insufficient for the initial local staging of prostate cancer (PC). This study aimed to compare the diagnostic accuracy of 68Ga-PSMA-11 PET/CT and multiparametric magnetic resonance imaging (mpMRI) for localised or locally advanced PC. Methods: We retrospectively reviewed patients who underwent preoperative 68Ga-PSMA-11 PET/CT and prostate mpMRI followed by radical prostatectomy (RP) at two tertiary institutions between August 2022 and April 2026. Side-specific PC, extraprostatic extension (EPE) and seminal vesicle invasion (SVI) were assessed using two imaging modalities and compared to pathologic T staging via RP. The diagnostic performance of 68Ga-PSMA-11 PET/CT and mpMRI was investigated. Results: Overall, 440 patients were included. Regarding side-specific PC detection, 68Ga-PSMA-11 PET/CT showed significantly higher sensitivity than mpMRI (72.9% vs. 61.8%, p < 0.001), whereas mpMRI had higher specificity (93.3% vs. 76.7%, p = 0.009). The two modalities showed similar overall discrimination (area under the receiver operating characteristic curve [AUC], 0.748 vs. 0.776, p = 0.323). For EPE, mpMRI had higher sensitivity than 68Ga-PSMA-11 PET/CT (42.3% vs. 7.1%, p < 0.001), whereas 68Ga-PSMA-11 PET/CT had higher specificity (96.1% vs. 84.5%, p < 0.001). Overall performance favoured mpMRI (AUCs, 0.634 vs. 0.516; p < 0.001). For SVI, mpMRI outperformed 68Ga-PSMA-11 PET/CT in sensitivity (48.7% vs. 20.5%, p = 0.002) and overall discrimination (AUC, 0.730 vs. 0.598; p = 0.001), while specificity was comparable (97.3% vs. 99.0%, p = 0.052). Conclusions: 68Ga-PSMA-11 PET/CT shows promise for the initial local staging of PC. The higher sensitivity of 68Ga-PSMA-11 PET/CT for localised PC suggests a potential complementary role in surgical planning. Conversely, in patients with EPE or SVI, mpMRI provides superior diagnostic performance overall.
Authors
- Seong Hyeon Yu (ORCID: https://orcid.org/0000-0002-1761-2025)
- Taek Won Kang (ORCID: https://orcid.org/0000-0002-7708-819X)
- Jang Bae Moon (ORCID: https://orcid.org/0000-0001-7183-2427)
- Sung Sun Kim (ORCID: https://orcid.org/0000-0002-8569-2178)
- Sang‐Geon Cho (ORCID: https://orcid.org/0000-0002-1373-1887)
- Hui Mo Gu (ORCID: https://orcid.org/0009-0001-7648-1758)
- Nah Ihm Kim (ORCID: https://orcid.org/0000-0001-6215-8549)
- Eu Chang Hwang (ORCID: https://orcid.org/0000-0002-2031-124X)
- Seung Il Jung (ORCID: https://orcid.org/0000-0003-4864-8175)
- Ho Seok Chung (ORCID: https://orcid.org/0000-0001-9883-1539)
- Suk Hee Heo (ORCID: https://orcid.org/0000-0002-9497-8952)
- Dongdeuk Kwon (ORCID: https://orcid.org/0000-0002-4544-5420)
Institutions
- Chonnam National University (KR)
- Chonnam National University Hospital (KR)
- Chonnam National University Hwasun Hospital (KR)
Publication Details
- Journal
- Cancers
- Published
- 2026-11-19
- DOI
- https://doi.org/10.3390/cancers18223697
- Primary Topic
- Prostate Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00